In today’s business landscape, corporate accountability in environmental reporting has become a critical measure of a company’s commitment to sustainability. Transparent disclosure of environmental performance not only fosters trust among stakeholders but also drives meaningful progress toward global environmental goals.

While the new administration seems reluctant to revisit the mistakes of the past five years, many of us are not ready to move on. Personally, I am still seeing vaccine injuries, I am still having trouble getting my patients ivermectin, and I am still fighting to keep my license. The emergency ended a long time ago, but all babies are expected to get three mRNA shots by the age of nine months. COVID mRNA shots are still under EUA status for children under twelve, and shockingly, nine million American children have received the latest version.

COVID was a bioweapon, and the pandemic was a war ⎯ a war on free speech, a war on informed consent, a war on patient autonomy, and a war on the doctor-patient relationship. The war is seemingly over, yet we have no treaty. We cannot heal, we cannot learn, we cannot move on if the events of the past five years are simply swept under the rug. No one has been held accountable; the perpetrators have only been empowered.

Aside from the man-made virus unleashed upon the world, the bulk of ammunition used to fight this war was information, and one of the first warriors to use it was Ed Dowd.

Financial guru Ed Dowd made one of the earliest counterattacks during the pandemic. As a Wall Street analyst, Ed has always been attuned to early signals of change. Before anyone else, Ed and his team at Phinance Technologies compiled extensive data demonstrating the harmful effects of the COVID shots. His website, Phinance Technologies’ Humanity Project, and book “Cause Unknown” detail this analysis of excess deaths and disability data during the pandemic.

Ed and his team examined disability trends in the United States, focusing on data from 2008 onwards, with a particular emphasis on changes observed during and after the COVID-19 pandemic. Starting in February 2021, their data showed a marked increase in disabilities across various population cohorts, especially among those aged 16 to 64, with the long-term average disability rate of 7.5% rising sharply. Their data showed a statistically significant increase in disability rates in Q3 and Q4 2021 following the rollout of the COVID shots.

Their report further explored how these trends affected different age groups and workforce participation. For the employed population aged 16 and over, a noticeable rise in disabilities began around May 2021, with the disability rate in the 16-64 workforce increasing from 3.1% in April 2021 to 3.9% by September 2022 — a 25.8% rise. Among those aged 65 and older, disabilities recovered to pre-pandemic levels by early 2021, followed by a sharp increase.

When they looked at excess death rates during this period, they found elevated excess mortality in 2021, with notable increases in the third and fourth quarters. Excess death rates rose significantly in 2021 compared to pre-pandemic trends, with peaks aligning with vaccination rollout — by July, over 50% of the U.S. population had received at least one dose, per CDC data — placing Q3 (July-September) and Q4 (October-December) in a post-vaccination surge timeframe. At the same time, life insurance industry reports, like OneAmerica’s, highlighted a 40% rise in death rates among working-age individuals in Q3 2021 compared to pre-pandemic levels, a period following the vaccine surge.

Phinance Technologies also focused on trends in death rates from neoplasms across all age groups in the United States, with a detailed focus on the 75-84 age bracket, using data from the CDC. The analysis revealed that overall neoplasm death rates steadily declined from 2010 to 2019, but notable shifts occurred during and after the COVID-19 pandemic. In 2020, excess mortality from neoplasms as the underlying cause (UC) was slightly negative at -0.5%. However, this trend reversed sharply in 2021 and 2022, with excess UC neoplasm deaths rising to +2.0% and +5.0%, respectively.

For the 75-84 age group, the report provides a more granular analysis, showing a significant uptick in neoplasm-related mortality post-2020. Excess UC neoplasm deaths in this cohort were -0.1% in 2020 (Z-score -0.3) but surged to +4.8% in 2021 (Z-score 10.1) and +11.5% in 2022 (Z-score 24.0), both highly statistically significant increases. When considering neoplasms as a multiple cause (MC) of death, the trend begins earlier, with excess mortality at +3.4% in 2020, +9.2% in 2021, and +16.4% in 2022.

In addition to death and disability data, the group examined the accuracy of COVID-19 death reporting in the United States, suggesting deaths attributed to COVID-19 as the underlying cause (UC) may have been significantly over-reported, particularly in 2020 and 2021. The analysis used CDC data to compare excess deaths from natural causes (excluding accidents, suicides, and homicides) with UC COVID-19 deaths, revealing that in 2020, UC COVID-19 deaths exceeded total excess natural deaths by approximately 13% (around 48,000 deaths). This discrepancy narrowed in 2021 to about 5% (roughly 20,000 deaths) and disappeared by 2022, where UC COVID-19 deaths aligned more closely with excess natural mortality. The report hypothesized that this over-reporting may stem from misclassification of deaths where COVID-19 was present but not the primary cause.

The study further explored age-specific trends, noting that over-reporting was most pronounced in younger age groups (0-44) and decreased with age. For instance, in 2020, UC COVID-19 deaths in the 15-24 and 25-34 age brackets exceeded excess natural deaths by factors of 2.6 and 1.7, respectively, while in older groups (65+), the ratios were closer to or below 1.0. By 2022, these discrepancies largely resolved, with UC COVID-19 deaths falling below excess natural deaths across most age groups. The report concludes that while some over-reporting likely occurred — potentially inflating COVID-19 mortality figures by 5-13% in 2020-2021 — the exact extent remains uncertain, calling for further investigation into death certificate accuracy and the role of comorbidities.

Ed and his team have recently published a full report on the outlook for the US Economy in 2025. Follow Ed on X @DowdEdward.

https://www.americaoutloud.news/the-numbers-speak-for-themselves-where-is-the-accountability/?utm_source=twitter&utm_medium=website&utm_campaign=SocialSnap